期刊文献+

苗药金乌健骨汤对寒湿阻络型类风湿关节炎患者生存质量的影响 被引量:15

Effect of Miao Medicine Jinwu Jiangu Decoction on the Life Quality of Patients with Rheumatoid Arthritis
下载PDF
导出
摘要 目的:探讨苗药金乌健骨汤对类风湿关节炎患者生存质量的影响。方法:将80例类风湿节炎患者随机分为治疗组和对照组,每组40例。两组均给予甲氨蝶呤10mg,每周1次口服,对照组在此基础上加用尫痹片,每次4片,每日3次口服;治疗组加用苗药金乌健骨汤,每日1剂口服;两组治疗时间均为3个月。结果:对照组完成治疗33例,有效率占69.70%;治疗组完成治疗35例,有效率占85.71%。两组比较,差异有统计学意义(P<0.01)。两组患者治疗后生存质量各项指标均有明显改善(P<0.01或P<0.05)。治疗组在生理功能、社会功能及健康自我认识三个方面优于对照组(P<0.01或P<0.05)。结论:苗药金乌健骨汤能够提高类风湿关节炎患者临床疗效,改善生活质量。 Objective:To investigate effect of miao medicine jinwu jiangu decoction on the life quality of patients with rheumatoid arthritis.Methods:80 patients with RA were equally randomized into the treatment group and the control group.Both groups were given methotrexate ( 10mg ) orally,1 time a week and the control group was also given wangbi tablets based on above treatment,4 tablets once and 3 times a day;the treatment group was added with miao medicine jinwujiangu decoction, 1 dose a day;both groups were treated for 3 months.Results:33 cases completed their treatment in the control group,effective rate being 69.70% and 35 cases completed their treatment in the treatment group,effective rate being 85.71%.The difference between the two groups was statistically significant (P 〈 0.01 ) .Survival quality indicators of the two groups significantly improved after treatment (P 〈 0.01 or P 〈 0.05 ) .The treatment group was better than the control group on the aspects of physiological function,social function and self-awareness of health ( P 〈 0.01 or P 〈 0.05 ) . Conclusion:Miao medicine jinwu jiangu decoction can enhance the clinical efficacy of patients with rheumatoid arthritis,improving the quality of their lives.
出处 《风湿病与关节炎》 2013年第7期8-11,共4页 Rheumatism and Arthritis
基金 贵州省社会发展攻关计划课题(2010GZ66925) 贵州省中医药管理局课题(2010021) 贵州省中医药民族医学重点学科项目(2012年)
关键词 关节炎 类风湿 生存质量 寒湿阻络型 金乌健骨汤 arthritis rheumatoid quality of life cold-dampness arthritis jinwujiangu decoction
  • 相关文献

参考文献7

  • 1Pugner KM, Scott DI, Holmes JW, et al. The costs of rheumatoid arthritis: an international long-term view[ J 1. Semin Arthritis Rheum,2000,29 ( 5 ) :305-320.
  • 2Pincus T, Callahan LF, Sale WG, et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years [ J 1. Arthritis Rheum,1984,27 ( 8 ) :864-872.
  • 3马武开,钟琴,姚血明,刘正奇,唐芳,安阳,黄颖.苗药金乌健骨汤治疗类风湿关节炎临床观察[J].中华中医药杂志,2010,25(12):2190-2192. 被引量:29
  • 4马武开,姚血明,唐芳,黄颖,王莹,安阳,钟琴,刘正奇.类风湿关节炎患者生活质量调查分析[J].中华中医药杂志,2011,26(11):2734-2736. 被引量:19
  • 5蒋明,朱立平.风湿病学[M].北京:科学出版社,1996.1470.
  • 6国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:85-89.
  • 7姜林娣,季建林,王吉耀,梅振武.类风湿关节炎生命质量量表的编制[J].中国行为医学科学,1999,8(1):9-12. 被引量:90

二级参考文献15

  • 1丁永明,傅华,朱靳良,傅东波.关节炎对生活质量的影响及防治对策[J].上海预防医学,2000,12(10):489-490. 被引量:19
  • 2刘健,程华威,郭雯,黄传兵.类风湿性关节炎生活质量调查[J].中国临床保健杂志,2006,9(2):106-108. 被引量:65
  • 3费立鹏 Henderson G.医学社会科学的临床应用:医学社会科学在临床科研的设计和评价中的使用[M].上海临床流行病中心,1997..
  • 4Rheumatoid arthritis:the status and future of combination therapy. Proceedings of a meeting.Chatham,Massachusetts,USA,July 13-15,1995.J Rheumatol Suppl,1996,44:110.
  • 5Arnett F C,Edworthy S M,Bloch B A,et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum,1988,31(3):315-324.
  • 6Prevoo M L,Hof M A,Kuper H H,et al.Modified disease activity scores include twenty-eight-joint counts.Development and alidation in a prospective longitude study of patients with rheumatoid arthritis.Arthritis Rheum,1995,38(1):d4-52.
  • 7Knijff-Dutmer E,Drossaers-Bakker W,Verhoeven A,et al.Rheumatoid factor measured by fluoro immunoassay:a responsive measure of rheumatoid arthritis disease activity that is associated with joint damage.Ann Rheum Dis,2002,61(7):603-607.
  • 8Vittecoq O,Pouplin S,Krzanowska K,et al.Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients.Rheumatology(Oxford),2003,42(8):939-946.
  • 9Kreot EJJA,De Jong BAW,Van Leeuwen MA,et al.The prognostic value anticyclic citrullinated peptide antibody in patients with recent onset rheumatoid arthrlti.Arthritis Rheum,2000,43(8):1831- 1835.
  • 10Yeh E T,Willerson J T.Coming of age of C-reactive protein:using inflammation markers in cardiology.Circulation,2003,107(3):370- 381.

共引文献373

同被引文献130

引证文献15

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部